Component
Human perceived sweetness of sucrose solution
Species, assay, exposure and limitations are retained on linked claims.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Adding gamma-nonalactone increased rated sweetness of 5% sucrose solution by a reported 23.0% at the optimal tested concentration.
Experimental context and source evidence
- dose
- Gamma-nonalactone concentration series; optimal sweetness reported at 10 mg/kg solution; propylene glycol used at 0.1-0.2% for poorly soluble compounds
- duration
- Acute sensory sessions; at least 2 min between samples
- evidence_access
- Primary full-text methods/results inspected; PubMed metadata where indexed.
- evidence_scope
- literature_reviewed; model-specific source-derived curation
- experimental_model
- Ten trained human sensory evaluators; five men and five women, mean age 24 years
- limitations
- Small trained panel and matrix-specific perception, not a glycemic or dietary-intake trial. Docking and molecular dynamics do not prove T1R2/T1R3 activation or binding.
- nutrient_topic
- Gamma-nonalactone flavor-compound chapter; nutrient and drug interactions retain their experimental settings. · Gamma-nonalactone
- organism
- Ten trained human sensory evaluators; five men and five women, mean age 24 years
- plain_language
- Adding gamma-nonalactone increased rated sweetness of 5% sucrose solution by a reported 23.0% at the optimal tested concentration.
- primary_references
- Sweetness enhancement and mechanism by sweet aroma compounds in the sucrose solution using sensory, electronic tongue, molecular docking, and molecular dynamics simulation. (2026). https://pubmed.ncbi.nlm.nih.gov/41884462/ DOI: 10.1016/j.fochx.2026.103753
- route
- Oral tasting followed by expectoration
- tissue
- Sweetness ratings in 5% sucrose solution
Gamma-nonalactone: mechanisms, molecular forms and cross-actor connections (2026-09-20) · lines 235–244
Original AI-assisted curation of eight primary studies. Study-specific citations, negative findings and limitations retained. Not publisher full text. · supports · Ten trained human sensory evaluators; five men and five women, mean age 24 years · source_derived_draft · unverified_draft
## gamma-nonalactone-sucrose-sweetness Adding gamma-nonalactone increased rated sweetness of 5% sucrose solution by a reported 23.0% at the optimal tested concentration. Model/species: Ten trained human sensory evaluators; five men and five women, mean age 24 years Tissue: Sweetness ratings in 5% sucrose solution Exposure: Gamma-nonalactone concentration series; optimal sweetness reported at 10 mg/kg solution; propylene glycol used at 0.1-0.2% for poorly soluble compounds Route: Oral tasting followed by expectoration Duration: Acute sensory sessions; at least 2 min between samples Limits: Small trained panel and matrix-specific perception, not a glycemic or dietary-intake trial. Docking and molecular dynamics do not prove T1R2/T1R3 activation or binding. Primary reference: Sweetness enhancement and mechanism by sweet aroma compounds in the sucrose solution using sensory, electronic tongue, molecular docking, and molecular dynamics simulation. (2026). https://pubmed.ncbi.nlm.nih.gov/41884462/ DOI: 10.1016/j.fochx.2026.103753 Access: Primary full-text methods/results inspected; PubMed metadata where indexed.
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.